4 Reasons Social Security Is In Trouble - Will You Be, Too?
13 Ways Beyond Coupons to Save on Groceries
Monkeys' Behavior Reveals Hidden Threat to Our Wealth
Can Apple Restore the Luster of the iPad?
Is Celgene the Perfect Stock?
Biotechnology company Celgene (CELG) announced it is buying Abraxis BioScience (ABII) for $2.9 billion in cash and stock. With this acquisition, Ceglene is expanding its portfolio of cancer treatments.